P495: PHASE 2 STUDY OF ASTX727 (DECITABINE/CEDAZURIDINE) PLUS VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR PREVIOUSLY UNTREATED, ELDERLY PATIENTS UNFIT FOR CHEMOTHERAPY. (23rd June 2022) - Abuasab, T.; Alvarado, Y.; Issa, G.; Islam, R.; Short, N.; Yilmaz, M.; jain, N.; Masarova, L.; Kornblau, S.; Jabbour, E.; Pemmaraju, N.; Montalban-Bravo, G.; et al.